Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference12 articles.
1. Old drugs for a new bug;Vastag;JAMA,2003
2. Bonanno, J. B.; Fowler, R.; Gupta, S.; Hendle, J.; Lorimer, D.; Romero, R.; Sauder, M.; Wei, C. L.; Liu, E. T.; Burley, S. K.; Harris, T. X-ray Crystal Structure of the SARS Coronavirus Main Protease, to be published (http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1Q2W), 2003
3. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor;Yang;Proc. Natl. Acad. Sci. U.S.A.,2003
4. Structural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutant;Lindberg;Eur. J. Biochem.,2002
5. Crystal structures of HIV-1 reverse transcriptase in complex with carboxanilide derivatives;Ren;Biochemistry,1998
Cited by 88 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives;International Journal of Molecular Sciences;2024-01-06
2. Effects of Shallomin with Lopinavir/Ritonavir on clinical outcomes and mortality in COVID-19 patients: A randomised double-blind clinical trial study;Journal of Herbal Medicine;2023-09
3. Artificial intelligence based virtual screening study for competitive and allosteric inhibitors of the SARS-CoV-2 main protease;Journal of Biomolecular Structure and Dynamics;2023-03-21
4. HIV and COVID-19 Disease;Seminars in Respiratory and Critical Care Medicine;2023-01-16
5. Molecular insights to the binding interactions of APNS containing HIV-protease inhibitors against SARS-CoV-2 Mpro: an in silico approach towards drug repurposing;Journal of Biomolecular Structure and Dynamics;2022-04-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3